Skip to content

Author

Wan-Ting Huang

We have 2 of 13 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

EP416 - ECE_1411 - Risk of incident chronic obstructive pulmonary disease in type 2 diabetes treated with SGLT2 inhibitors or GLP-1 receptor agonists vs DPP-4 inhibitors: a Real-World Cohort Study

SGLT2is and GLP-1 RAs were associated with a significantly lower risk of incident COPD compared with DPP4is in patients with T2D, which supports the potential respiratory-protective pleiotropic effects of these agents and may inform treatment selection for patients with T2D at risk for chronic lung disease.

Wei-Chuan Chang, Alice Yi-Yun Chan, Wan-Ting Huang et al. · 0 citations
Open access Jul 2026

Exploring the connection between organophosphate flame retardants and Hyperlipidemia: an integrated analysis using NHANES (2011–2018), network toxicology, and mendelian randomization

An association between OPFRs exposure and hyperlipidemia is supported and a potential multi-target, multi-pathway regulatory mechanism is suggested, which suggests a potential multi-target, multi-pathway regulatory mechanism.

Chen Zeng, Wan-Ting Huang, Piao Zhou et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.